Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production

Enhertu granted priority review in US for patients with HER2-positive metastatic breast cancer
Enhertu, manufactured by AstraZeneca and Daiichi Sankyo, has been accepted for the treatment of adult patients in the US with unresectable or...
SMC accept Enhertu for the treatment of HER2 positive metastatic breast cancer
Daiichi Sankyo and AstraZeneca have announced that the SMC has accepted Enhertu® for use within NHS Scotland for the treatment of HER2 positive...
Almirall and IRB Barcelona research for skin disease therapeutics discovery
Almirall and IRB Barcelona (the Institute for Research in Biomedicine) have announced a research collaboration to identify the new oral treatments...
Abbisko Therapeutics collaborates with Lilly to discover novel molecules
Abbisko Therapeutics announced that it has entered into a partnership and exclusive licensing agreement with Eli Lilly and Company. This...
>> More Manufacturing and Production News Stories

Features

Outsourcing in clinical trials: A response to rising challenges

Clinical trials are complex, multifaceted projects, and this makes them infamously expensive to run, but outsourcing to contract research...

>> More Features

Appointments

Julie Beeso joins Envision Pharma Group as new Global Director

Envision Pharma Group has appointed Julie Beeso as its Global Director, Professional Development and Engagement. Julie has worked for almost 25...

For more appointments click here

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches